The
wide use of the antimicrobial agent/biocide, triclosan, promotes
triclosan-resistant bacterial strains, including
Staphylococcus
aureus
, as well as leads to accumulation in the aquatic
and terrestrial environments. Knowledge of the molecular actions of
triclosan on
S. aureus
is needed to
understand the consequence of triclosan resistance and environmental
accumulation of triclosan on
S. aureus
resistant strains, as well as to develop biphenyl ether analogs
as antibiotic candidates. Triclosan inhibits an essential enzyme in
the fatty acid biosynthetic pathway, the reduced nicotinamide adenine
dinucleotide (NADH)/reduced nicotinamide adenine dinucleotide phosphate
(NADPH)-dependent enoyl-acyl carrier protein (enoyl-ACP) reductase,
or FabI. In this study, we used error-prone polymerase chain reaction
(epPCR) to generate mutations in the
S. aureus
FabI enzyme. Instead of using an elaborate FabI enzyme activity
assay that involves ACP-linked substrates to determine whether triclosan
inhibits the enzyme activities of individual FabI mutants, we used
an efficient and economical assay that we developed, based on thermal
shift principles, to screen for triclosan binding to FabI mutants
in cells. We identified four active-site mutations. More interestingly,
we also identified nine triclosan-resistant mutations distant from
the active site (G113V, Y123H, S166N, N220I, G227C, A230T, V241I,
F252I, and H253P) but located in disparate positions in the monomer–monomer
and dimer–dimer interface regions in
S. aureus
FabI. We suggest that these sites may serve as potential allosteric
sites for designing potential therapeutic inhibitors that offer advantages
in selectivity since allosteric sites are less evolutionarily conserved.